Buying IV Solutions Wholesale: Saline, Dextrose, and Lactated Ringers by the Case

IV solutions are the highest-volume sterile product most facilities buy, and four families cover the large majority of demand: sodium chloride (saline), dextrose, lactated Ringers, and sterile water. They are supplied in flexible bags from 50 mL minibags through 1,000 mL, ordered by the case. The 2024-2025 national shortage reset how procurement teams think about this category. After Hurricane Helene flooded the plant that supplied roughly 60% of the U.S. IV fluid supply, facilities spent months on allocation. FDA removed 0.9% sodium chloride injection from its shortage list in August 2025. The lesson buyers carried forward is that a single-source IV fluid strategy is a risk position, not a savings position.

For a hospital, surgery center, or urgent care clinic, IV solutions are a recurring, high-frequency purchase with almost no clinical substitutability at the moment of use. When a 1,000 mL bag of 0.9% sodium chloride is not on the shelf, the case does not proceed. That combination of high volume and low substitutability is what makes IV fluid procurement a different exercise from most med-surg categories, and it runs through the whole infusion chain from the bag to the Administration Set to the peripheral catheter. This guide covers the solution families, the bag sizes that shape an order profile, and how facilities build a fluid formulary that holds up when supply tightens. Clinical selection for any individual patient stays where it belongs: with the care team.

What Are IV Solutions?

IV solutions are sterile fluids packaged in flexible bags for intravenous administration, used for hydration, electrolyte replacement, as a vehicle for drug delivery, and for line maintenance. From a buyer's standpoint, three attributes define any given SKU: the solution family, the fill volume, and the bag material and port configuration.

Bag material has become a procurement variable in its own right. Traditional flexible IV bags are PVC plasticized with DEHP, and a California statute now sets a phase-out clock on that construction. We cover the compliance detail and the EVA alternatives in our guide to sourcing non-DEHP and non-PVC IV bags.

The Four Solution Families a Facility Stocks

Nearly all IV solution volume in a general facility falls into four families. The table below pairs each with the concentrations and bag sizes buyers actually see on a purchase order.

Multi-electrolyte solutions such as Isolyte sit alongside these four in facilities with specific perioperative or critical care protocols, and are stocked in smaller defined quantities.

Why Fill Volume Drives the Order Profile More Than Family

Buyers new to this category tend to think in terms of solution families. Experienced materials managers think in terms of fill volumes, because that is where the storage math and the allocation risk concentrate.

A 1,000 mL bag occupies far more shelf space per unit than a 100 mL minibag and moves at a completely different velocity, and the case counts reflect it: 1,000 mL ships 10 to 14 per case while 100 mL ships 64 to 96. During the 2024 allocation period, 1,000 mL saline was the constrained item at most facilities while minibags remained comparatively available, because pharmacy compounding, drug delivery, and line maintenance consume small volumes at high frequency while resuscitation and perioperative hydration consume large volumes in bursts. A facility that models par levels by family rather than by fill volume will get the storage plan and the reorder point wrong on both ends.

What the 2024-2025 Shortage Changed for Buyers

On September 26, 2024, Hurricane Helene made landfall and flooded Baxter's North Cove manufacturing site in western North Carolina. Roughly 60% of the national IV fluid supply came from that one plant. Within weeks, hospitals across the country were postponing elective procedures, rationing 1,000 mL saline bags, and substituting oral hydration where clinically acceptable.

The federal response was unusually fast. The Biden administration invoked the Defense Production Act to accelerate the plant's recovery, FDA authorized extended use dates on certain products and cleared temporary imports from Europe and Asia, and Baxter had eight of ten manufacturing lines restarted by mid-December 2024. FDA removed 0.9% sodium chloride injection from its shortage list in August 2025, formally closing the event.

What did not reset is the procurement posture. A Boise State College of Business analysis found that 20% of U.S. hospitals shifted toward broader local and diversified sourcing during 2024. For IV fluids specifically, the practical change was that buyers who had a qualified secondary or contingency vendor relationship in place before the storm moved through the allocation period with materially less disruption than buyers who started making calls in October. Building that relationship is cheap when you do not need it and impossible to build quickly when you do.

Building an IV Fluid Formulary That Holds Under Allocation

The formulary question for IV solutions is narrower than for most categories, because the clinical set is small and standardized. The procurement work is in three areas.

• Concentration discipline. Facilities accumulate combination solutions (D5 with varying saline concentrations, LR with dextrose) that duplicate each other across departments. Auditing usage by SKU over 6 to 12 months usually reveals several low-turn concentrations that can be consolidated without clinical objection.
• Fill-volume par levels set separately. Model minibags and large-volume bags as distinct inventory problems with their own reorder points, because their demand curves and storage footprints do not correlate.
• A qualified contingency vendor, documented before you need it. This is the direct lesson of 2024. The account should exist, the SKUs should be cross-referenced, and pricing should be on file.

That third point is where most facilities were unprepared. If you want a cross-reference built against your current fluid formulary so a second source is ready rather than theoretical, our team can put that together with case-quantity pricing.

How to Buy IV Solutions in Bulk

IV solutions ship by the case, and case count tracks fill volume closely. Across the references we stock, 1,000 mL bags run 10 to 14 per case, 250 mL and 500 mL bags run 20 to 36 per case, and 50 mL and 100 mL minibags run 64 to 96 per case. Case quantity ordering is the default for the high-turn references because the cost per bag drops meaningfully and because fluid has a long enough dating window that reasonable overstock does not create waste risk the way low-turn specialty items do.

Storage capacity is the practical ceiling. Fluid is bulky and heavy, and a facility with limited clean storage cannot simply order a quarter ahead. That constraint argues for a distributor who can support a more frequent delivery cadence without penalizing smaller orders.

Driven by an obsession with customer experience, MAP Medical works as a single-source wholesale partner for clinics, surgery centers, hospitals, and multi-site networks across the U.S., Canada, and EMEA, supplying Baxter, B Braun, ICU Medical, and Grifols IV solutions across the fill volumes facilities actually run. Buyers come to us when a primary vendor falls short and stay because we work like an extension of their own purchasing team.

What This Means for Procurement Teams

IV solutions are a small clinical set and a large logistical problem. Model par levels by fill volume rather than by solution family, consolidate the low-turn combination concentrations that accumulate across departments, and hold a qualified second source that is documented before you need it. MAP Medical is a wholesale medical supply distributor built around three things facility buyers tell us they need most: responsive service, fast turnaround, and single-source ordering across thousands of critical med-surg supplies. We carry the solution families above at wholesale pricing, with a team that responds the same day when a buyer needs an answer. If you are qualifying a contingency vendor or rebuilding your fluid par levels, we are happy to build the cross-reference against your current formulary.

Our IV Solutions Catalog

The references below cover sodium chloride, dextrose, lactated Ringers, and multi-electrolyte solutions from Baxter, B Braun, ICU Medical, and Grifols, prioritized by buyer demand. You can find the selected products in the table below.

Get wholesale pricing on IV solutions - with the service and speed your facility deserves. Contact MAP Medical to optimize your formulary today.